Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 68
Filter
Add more filters










Publication year range
1.
Crit Rev Eukaryot Gene Expr ; 13(2-4): 243-53, 2003.
Article in English | MEDLINE | ID: mdl-14696971

ABSTRACT

The P2X7 receptor is a member of the family of P2X purinergic receptors, which upon sustained activation forms large pores in the plasma membrane. In cells of hematopoietic origin, P2X7 receptor activation has been shown to lead to multiple downstream events, including cytokine release, cell permeabilization, and apoptosis. This receptor has also been implicated in the generation of multinucleated giant cells, polykaryons, and osteoclasts. We have recently demonstrated that a blockade of this receptor inhibits osteoclast formation in vitro; therefore, we examined mice deficient in the P2X7 receptor in the context of bone. These mice were healthy and displayed no overt skeletal problems. Furthermore, we were able to demonstrate their ability to form multinucleated cells, in particular osteoclasts, both in vivo and in vitro. We also demonstrate the ability of P2X7R-/- multinucleated osteoclasts, upon stimulation with maitotoxin (MTX), to form pores in the plasma membrane in vitro. These findings are consistent with the existence of an endogenous pore structure present in osteoclast precursor cells that can be activated either by the P2X7 receptor, or in its absence, by alternative signals to mediate fusion and pore formation. These data provide further insight into the mode of action of the P2X7 receptor.


Subject(s)
Osteoclasts/metabolism , Receptors, Purinergic P2/genetics , Receptors, Purinergic P2/physiology , Animals , Apoptosis , Blotting, Southern , Cell Fusion , Cell Membrane/metabolism , Cell Nucleus/metabolism , Cells, Cultured , Densitometry , Ethidium/pharmacology , Fluorescent Dyes/pharmacology , Genotype , In Vitro Techniques , Marine Toxins/pharmacology , Mice , Mice, Transgenic , Mutation , Oxocins/pharmacology , Phenotype , Receptors, Purinergic P2X7 , Spleen/cytology
2.
Microb Drug Resist ; 7(2): 99-125, 2001.
Article in English | MEDLINE | ID: mdl-11442348

ABSTRACT

The public availability of numerous microbial genomes is enabling the analysis of bacterial biology in great detail and with an unprecedented, organism-wide and taxon-wide, broad scope. Streptococcus pneumoniae is one of the most important bacterial pathogens throughout the world. We present here sequences and functional annotations for 2.1-Mbp of pneumococcal DNA, covering more than 90% of the total estimated size of the genome. The sequenced strain is a clinical isolate resistant to macrolides and tetracycline. It carries a type 19F capsular locus, but multilocus sequence typing for several conserved genetic loci suggests that the strain sequenced belongs to a pneumococcal lineage that most often expresses a serotype 15 capsular polysaccharide. A total of 2,046 putative open reading frames (ORFs) longer than 100 amino acids were identified (average of 1,009 bp per ORF), including all described two-component systems and aminoacyl tRNA synthetases. Comparisons to other complete, or nearly complete, bacterial genomes were made and are presented in a graphical form for all the predicted proteins.


Subject(s)
Genome, Bacterial , Pneumococcal Infections/microbiology , Streptococcus pneumoniae/genetics , DNA, Bacterial/chemistry , DNA, Bacterial/genetics , Genes, Bacterial/genetics , Molecular Sequence Data , Prokaryotic Cells , RNA, Transfer/metabolism
3.
Am J Physiol Cell Physiol ; 280(4): C943-53, 2001 Apr.
Article in English | MEDLINE | ID: mdl-11245611

ABSTRACT

P2X receptors function as ATP-gated cation channels. The P2X(7) receptor subtype is distinguished from other P2X family members by a very low affinity for extracellular ATP (millimolar EC50) and its ability to trigger induction of nonselective pores on repeated or prolonged stimulation. Previous studies have indicated that certain P2X(7) receptor-positive cell types, such as human blood monocytes and murine thymocytes, lack this pore-forming response. In the present study we compared pore formation in response to P2X(7) receptor activation in human blood monocytes with that in macrophages derived from these monocytes by in vitro tissue culture. ATP induced nonselective pores in macrophages but not in freshly isolated monocytes when both cell types were identically stimulated in standard NaCl-based salines. However, ion substitution studies revealed that replacement of extracellular Na+ and Cl- with K+ and nonhalide anions strongly facilitated ATP-dependent pore formation in monocytes. These ionic conditions also resulted in increased agonist affinity, such that 30-100 microM ATP was sufficient for activation of nonselective pores by P2X(7) receptors. Comparison of P2X(7) receptor expression in blood monocytes with that in macrophages indicated no differences in steady-state receptor mRNA levels but significant increases (up to 10-fold) in the amount of immunoreactive P2X(7) receptor protein at the cell surface of macrophages. Thus ability of ATP to activate nonselective pores in cells that natively express P2X(7) receptors can be modulated by receptor subunit density at the cell surface and ambient levels of extracellular Na+ and Cl-. These mechanisms may prevent adventitious P2X(7) receptor activation in monocytes until these proinflammatory leukocytes migrate to extravascular sites of tissue damage.


Subject(s)
Monocytes/metabolism , Potassium Chloride/pharmacokinetics , Receptors, Purinergic P2/metabolism , Sodium Chloride/pharmacokinetics , Adenosine Triphosphate/metabolism , Adenosine Triphosphate/pharmacology , Cells, Cultured , Extracellular Space/metabolism , Gene Expression/physiology , Humans , Inflammation/immunology , Inflammation/metabolism , Ion Channel Gating/drug effects , Ion Channel Gating/physiology , Ion Channels/immunology , Ion Channels/metabolism , Macrophages/cytology , Macrophages/immunology , Macrophages/metabolism , Monocytes/cytology , Monocytes/immunology , RNA, Messenger/analysis , Receptors, Purinergic P2/genetics , Receptors, Purinergic P2X7 , Sodium Glutamate/pharmacokinetics
4.
Am J Physiol Cell Physiol ; 279(4): C1189-97, 2000 Oct.
Article in English | MEDLINE | ID: mdl-11003599

ABSTRACT

Lymphocytes from normal subjects and patients with B-chronic lymphocytic leukemia (B-CLL) show functional responses to extracellular ATP characteristic of the P2X(7) receptor (previously termed P2Z). These responses include opening of a cation-selective channel/pore that allows entry of the fluorescent dye ethidium and activation of a membrane metalloprotease that sheds the adhesion molecule L-selectin. The surface expression of P2X(7) receptors was measured in normal leucocytes, platelets, and B-CLL lymphocytes and correlated with their functional responses. Monocytes showed four- to fivefold greater expression of P2X(7) than B, T, and NK lymphocytes, whereas P2X(7) expression on neutrophils and platelets was weak. All cell types demonstrated abundant intracellular expression of this receptor. All 12 subjects with B-CLL expressed lymphocyte P2X(7) at about the same level as B lymphocytes from normal subjects. P2X(7) function, measured by ATP-induced uptake of ethidium, correlated closely with surface expression of this receptor in normal and B-CLL lymphocytes and monocytes (n = 47, r = 0.70; P < 0.0001). However, in three patients the ATP-induced uptake of ethidium into the malignant B lymphocytes was low or absent. The lack of P2X(7) function in these B lymphocytes was confirmed by the failure of ATP to induce Ba(2+) uptake into their lymphocytes. This lack of function of the P2X(7) receptor resulted in a failure of ATP-induced shedding of L-selectin, an adhesion molecule that directs the recirculation of lymphocytes from blood into the lymph node.


Subject(s)
Adenosine Triphosphate/analogs & derivatives , Leukemia, Lymphocytic, Chronic, B-Cell/blood , Lymphocytes/metabolism , Monocytes/metabolism , Receptors, Purinergic P2/biosynthesis , Adenosine Triphosphate/metabolism , Adenosine Triphosphate/pharmacology , Antibodies, Monoclonal/metabolism , Barium/pharmacokinetics , Blood Platelets/metabolism , Ethidium/pharmacokinetics , Flow Cytometry , Humans , Intracellular Fluid/metabolism , L-Selectin/metabolism , Lymphocyte Subsets/drug effects , Lymphocyte Subsets/metabolism , Lymphocytes/drug effects , Monocytes/drug effects , Polymerase Chain Reaction , Purinergic P2 Receptor Agonists , RNA, Messenger/metabolism , Receptors, Purinergic P2/genetics , Receptors, Purinergic P2X7 , Reference Values
5.
Mol Biol Cell ; 11(9): 3169-76, 2000 Sep.
Article in English | MEDLINE | ID: mdl-10982408

ABSTRACT

Cell fusion is a central phenomenon during the immune response that leads to formation of large elements called multinucleated giant cells (MGCs) of common occurrence at sites of granulomatous inflammation. We have previously reported on the involvement in this event of a novel receptor expressed to high level by mononuclear phagocytes, the purinergic P2X(7) receptor. Herein, we show that blockade of this receptor by a specific monoclonal antibody prevents fusion in vitro. In contrast, cell fusion is stimulated by addition of enzymes that destroy extracellular ATP (i.e., apyrase or hexokinase). Experiments performed with phagocytes selected for high (P2X(7) hyper) or low (P2X(7) hypo) P2X(7) expression show that fusion only occurs between P2X(7) hyper/P2X(7) hyper and not between P2X(7) hyper/P2X(7) hypo or P2X(7) hypo/P2X(7) hypo. During MGCs formation we detected activation of caspase 3, an enzyme that is powerfully stimulated by P2X(7). Finally, we observed that during MGCs formation, the P2X(7) receptor is preferentially localized at sites of cell-to-cell contact. These findings support the hypothesis originally put forward by our group that the P2X(7) receptor participates in multinucleated giant cell formation.


Subject(s)
Adenosine Triphosphate/metabolism , Cell Fusion/physiology , Dendritic Cells/physiology , Giant Cells/cytology , Receptors, Purinergic P2/physiology , Animals , Antibodies, Monoclonal/pharmacology , Apyrase/metabolism , Caspase 3 , Caspases/metabolism , Cell Fusion/drug effects , Cell Line , Dendritic Cells/cytology , Giant Cells/physiology , Hexokinase/metabolism , Macrophages , Mice , Purinergic P2 Receptor Antagonists , Receptors, Purinergic P2X7
6.
Nature ; 403(6765): 86-9, 2000 Jan 06.
Article in English | MEDLINE | ID: mdl-10638758

ABSTRACT

P2X1 receptors for ATP are ligand-gated cation channels, present on many excitable cells including vas deferens smooth muscle cells. A substantial component of the contractile response of the vas deferens to sympathetic nerve stimulation, which propels sperm into the ejaculate, is mediated through P2X receptors. Here we show that male fertility is reduced by approximately 90% in mice with a targeted deletion of the P2X1 receptor gene. Male mice copulate normally--reduced fertility results from a reduction of sperm in the ejaculate and not from sperm dysfunction. Female mice and heterozygote mice are unaffected. In P2X1-receptor-deficient mice, contraction of the vas deferens to sympathetic nerve stimulation is reduced by up to 60% and responses to P2X receptor agonists are abolished. These results show that P2X1 receptors are essential for normal male reproductive function and suggest that the development of selective P2X1 receptor antagonists may provide an effective non-hormonal male contraceptive pill. Also, agents that potentiate the actions of ATP at P2X1 receptors may be useful in the treatment of male infertility.


Subject(s)
Infertility, Male/etiology , Receptors, Purinergic P2/physiology , Vas Deferens/physiopathology , Animals , Contraception , Ejaculation/physiology , Female , Gene Deletion , Infertility, Male/genetics , Male , Mice , Muscle Contraction , Muscle, Smooth/physiology , Pregnancy , Purinergic P2 Receptor Agonists , Receptors, Purinergic P2/deficiency , Receptors, Purinergic P2/genetics , Receptors, Purinergic P2X , Reproduction , Sperm Count , Sympathetic Nervous System/physiology
7.
J Biol Chem ; 274(47): 33206-8, 1999 Nov 19.
Article in English | MEDLINE | ID: mdl-10559192

ABSTRACT

Human leukocytes can express the P2X(7) purinergic receptor, an ionic channel gated by extracellular ATP, for which the physiological role is only partially understood. Transfection of P2X(7) cDNA into lymphoid cells that lack this receptor sustains their proliferation in serum-free medium. Increased proliferation of serum-starved P2X(7) transfectants is abolished by the P2X(7) receptor blocker oxidized ATP or by the ATP hydrolase apyrase. Both wild type and P2X(7)-transfected lymphoid cells release large amounts of ATP into the culture medium. These data suggest the operation of an ATP-based autocrine/paracrine loop that supports lymphoid cell growth in the absence of serum-derived growth factors.


Subject(s)
Cell Division/genetics , Lymphocytes/cytology , Receptors, Purinergic P2/genetics , Adenosine Triphosphate/metabolism , Base Sequence , DNA Primers , Humans , K562 Cells , Receptors, Purinergic P2X7
8.
J Leukoc Biol ; 66(5): 723-6, 1999 Nov.
Article in English | MEDLINE | ID: mdl-10577500

ABSTRACT

We have investigated the role of the purinergic P2X7 receptor in the formation of multinucleated giant cells in human monocyte/macrophage cultures stimulated with either concanavalin A or phytohemagglutinin. Macrophage fusion can be blocked by a P2X7-selective pharmacological antagonist or by a mAb directed against the extracellular P2X7 domain. Furthermore, macrophage cell clones expressing high P2X7 levels spontaneously fuse in culture, whereas macrophage clones lacking P2X7 are unable to fuse. Our findings suggest that the newly identified purinergic P2X7 receptor plays a central role in the complex chain of events leading to generation of macrophage-derived giant cells.


Subject(s)
Giant Cells/cytology , Receptors, Purinergic P2/physiology , Hexokinase/metabolism , Humans , Receptors, Purinergic P2X7
9.
Mol Pharmacol ; 56(5): 973-81, 1999 Nov.
Article in English | MEDLINE | ID: mdl-10531403

ABSTRACT

P2X receptors are membrane proteins that incorporate a cation-selective ion channel that can be opened by the binding of extracellular ATP. They associate as hetero- and homo-multimers of currently unknown stoichiometry. In this study, we have used Xenopus laevis oocytes to express rat P2X(2) receptor subunits, which carry a cysteine mutation at position 336. ATP-induced currents at this mutant receptor subunit were blocked by more than 90% when exposed to [2-(trimethylammonium) ethyl] methanethiosulfonate (MTSET), whereas currents from wild-type subunits were not affected. To compare mutant and wild-type channel expression, we introduced an epitope in their extracellular domains and found for both channels a similar linear relationship between antibody binding and currents induced by ATP. To study the contribution of the individual subunits to the block by MTSET, we coinjected different mixtures of wild-type and mutant-encoding mRNAs. We found that the inhibition by MTSET depended linearly on the proportion of mutant subunits, which was clearly contrary to the hypothesis that a single mutant subunit could act in a dominant fashion. Subsequent concatenation of wild-type and mutant-encoding cDNAs resulted in an inhibition by MTSET that also depended linearly on the number of mutant subunits and was independent of the position of the mutant subunit, as long as only two or three P2X(2) subunits were joined. With four or six subunits joined, however, the inhibition by MTSET became strongly position-dependent. The present results show that a "per-subunit" channel block causes the blocking effects of MTSET and they suggest that not four but maximally three subunits actively participate in the channel formation.


Subject(s)
Mesylates/pharmacology , Receptors, Purinergic P2/metabolism , Animals , DNA, Complementary/genetics , DNA, Complementary/metabolism , Mutation , Oocytes/drug effects , Oocytes/metabolism , Rats , Receptors, Purinergic P2/biosynthesis , Receptors, Purinergic P2/drug effects , Receptors, Purinergic P2/genetics , Receptors, Purinergic P2X2 , Xenopus laevis
10.
J Immunol ; 163(2): 558-61, 1999 Jul 15.
Article in English | MEDLINE | ID: mdl-10395640

ABSTRACT

Signaling by extracellular nucleotides through P2 purinergic receptors affects diverse macrophage functions; however, its role in regulating antimicrobial radicals during bacterial infection has not been investigated. Mycobacterium tuberculosis-infected macrophages released ATP in a dose-dependent manner, which correlated with nitrite accumulation. P2 receptor inhibitors, including oxidized ATP, blocked NO synthase (NOSII) up-regulation and NO production induced by infection with M. tuberculosis or bacille Calmette-Guérin, or treatment with LPS or TNF-alpha. Oxidized ATP also inhibited oxygen radical production and activation of NF-kappaB and AP-1 in response to infection and inhibited NO-dependent killing of bacille Calmette-Guérin by macrophages. Experiments using macrophages derived from P2X7 gene-disrupted mice ruled out an essential role for P2X7 in NOSII regulation. These data demonstrate that P2 receptors regulate macrophage activation in response to bacteria and proinflammatory stimuli, and suggest that extracellular nucleotides released from infected macrophages may enhance production of oxygen radicals and NO at sites of infection.


Subject(s)
Macrophages/immunology , Mycobacterium bovis/immunology , Mycobacterium tuberculosis/immunology , Receptors, Purinergic P2/physiology , Signal Transduction/immunology , Adenosine Triphosphate/analogs & derivatives , Adenosine Triphosphate/pharmacology , Animals , Cell Line , Free Radicals/immunology , Macrophage Activation/drug effects , Macrophage Activation/immunology , Macrophages/drug effects , Macrophages/enzymology , Macrophages/metabolism , Mice , Mycobacterium bovis/drug effects , Mycobacterium bovis/metabolism , Mycobacterium tuberculosis/drug effects , Mycobacterium tuberculosis/metabolism , Nitric Oxide/antagonists & inhibitors , Nitric Oxide/biosynthesis , Nitric Oxide/physiology , Nitric Oxide Synthase/antagonists & inhibitors , Nitric Oxide Synthase/biosynthesis , Nitric Oxide Synthase/genetics , Purinergic P2 Receptor Antagonists , Pyridoxal Phosphate/analogs & derivatives , Pyridoxal Phosphate/pharmacology , RNA, Messenger/antagonists & inhibitors , RNA, Messenger/metabolism , Reactive Oxygen Species/immunology , Reactive Oxygen Species/metabolism , Receptors, Purinergic P2X7 , Suramin/pharmacology
11.
Eur J Neurosci ; 10(11): 3470-8, 1998 Nov.
Article in English | MEDLINE | ID: mdl-9824460

ABSTRACT

The P2X3 receptor subunit, a member of the P2X family of ATP-gated ion channels, is almost exclusively localized in sensory neurons. In the present study, we sought to gain insight into the role of P2X3 and P2X3-containing neurons in sensory transmission, using immunohistochemical approaches. In rat dorsal root ganglia (DRG), P2X3-immunoreactivity (-ir) was observed in small- and medium-sized neurons. Approximately 40% of DRG neuronal profiles in normal rats contained P2X3-ir. In rats that had received neonatal capsaicin treatment, the number of P2X3-positive neurons was decreased by approximately 70%. Analysis of the colocalization of P2X3-ir with cytochemical markers of DRG neurons indicated that approximately 94% of the P2X3-positive neuronal profiles were labelled by isolectin B4 from Bandeiraea simplicifolia, while only 3% contained substance P-ir, and 7% contained somatostatin-ir. In dorsal horn of rat spinal cord, P2X3-ir was observed in the inner portion of lamina II and was reduced subsequent to dorsal rhizotomy, as well as subsequent to neonatal capsaicin treatment. Finally, P2X3-ir accumulated proximal to the site of sciatic nerve ligation, and was seen in nerve fibres in skin and corneal epithelium. In summary, our results suggest that P2X3 is expressed by a functionally heterogeneous population of BSI-B4-binding sensory neurons, and is transported into both central and peripheral processes of these neurons.


Subject(s)
Neurons/metabolism , Receptors, Purinergic P2/metabolism , Spinal Cord/metabolism , Spinal Nerve Roots/metabolism , Animals , Animals, Newborn , Capsaicin/toxicity , Epithelium, Corneal/innervation , Fluorescent Antibody Technique , Male , Microscopy, Confocal , Neurons, Afferent/metabolism , Rats , Rats, Sprague-Dawley , Receptors, Purinergic P2X3 , Sciatic Nerve/metabolism , Skin/innervation , Spinal Nerve Roots/cytology
12.
Recept Channels ; 5(6): 347-54, 1998.
Article in English | MEDLINE | ID: mdl-9826911

ABSTRACT

The genomic organization for the human P2X7 receptor gene was determined to comprise 13 exons. Alignment of the exon-intron junctions with those for the rat P2X2 gene demonstrated a precise conservation of the boundaries for the first 10 introns. The human P2X7 receptor gene was localized by in situ hybridization to chromosome 12q24. Radiation hybrid mapping indicated that this is within 130 kb of the gene for the homologous P2X4 receptor.


Subject(s)
Chromosome Mapping , Chromosomes, Human, Pair 12 , Genome, Human , Receptors, Purinergic P2/genetics , Animals , Base Sequence , Exons , Humans , Molecular Sequence Data , Rats , Receptors, Purinergic P2X7 , Sequence Analysis, DNA
13.
Blood ; 92(10): 3521-8, 1998 Nov 15.
Article in English | MEDLINE | ID: mdl-9808543

ABSTRACT

A monoclonal antibody (MoAb) specific for the human P2X7 receptor was generated in mice. As assessed by flow cytometry, the MoAb labeled human blood-derived macrophage cells natively expressing P2X7 receptors and cells transfected with human P2X7 but not other P2X receptor types. The MoAb was used to immunoprecipitate the human P2X7 receptor protein, and in immunohistochemical studies on human lymphoid tissue, P2X7 receptor labeling was observed within discrete areas of the marginal zone of human tonsil sections. The antibody also acted as a selective antagonist of human P2X7 receptors in several functional studies. Thus, whole cell currents, elicited by the brief application of 2',3'-(4-benzoyl)-benzoyl-ATP in cells expressing human P2X7, were reduced in amplitude by the presence of the MoAb. Furthermore, preincubation of human monocytic THP-1 cells with the MoAb antagonized the ability of P2X7 agonists to induce the release of interleukin-1beta.


Subject(s)
Antibodies, Monoclonal/pharmacology , Purinergic P2 Receptor Antagonists , Adenosine Triphosphate/analogs & derivatives , Adenosine Triphosphate/pharmacology , Adenosine Triphosphate/physiology , Animals , Antibodies, Monoclonal/immunology , Apoptosis/drug effects , Apoptosis/physiology , Calcium Signaling/drug effects , Calcium Signaling/physiology , Humans , Interleukin-1/metabolism , Leukemia, Monocytic, Acute/pathology , Mice , Mice, Inbred BALB C , Monocytes/drug effects , Monocytes/metabolism , Palatine Tonsil/cytology , Palatine Tonsil/immunology , Receptors, Purinergic P2/immunology , Receptors, Purinergic P2X7 , Second Messenger Systems/physiology
15.
J Biol Chem ; 273(24): 15177-82, 1998 Jun 12.
Article in English | MEDLINE | ID: mdl-9614131

ABSTRACT

Western blots of Xenopus oocyte membrane preparations showed that the apparent molecular mass of the wild type P2X2 receptor (about 65 kDa) was reduced by pretreatment with endoglycosidase H. Mutagenesis of one or more of three potential asparagines (N182S, N239S, and N298S) followed by Western blots showed that each of the sites was glycosylated in the wild type receptor. Functional channels were formed by receptors lacking any single asparagine, but not by channels mutated in two or three positions. Artificial consensus sequences (N-X-S/T) introduced into the N-terminal region (asparagine at position 9, 16, or 26) were not glycosylated. Asparagines were glycosylated when introduced at the C-terminal end of the first hydrophobic domain (positions 62 and 66) and at the N-terminal end of the second hydrophobic domain (position 324). A protein in which the C terminus of one P2X2 subunit was joined to the N terminus of a second P2X2 subunit (from a concatenated cDNA) had twice the molecular mass of the P2X2 receptor subunit, and formed fully functional channels. The experiments provide direct evidence for the topology originally proposed for the P2X receptor, with intracellular N and C termini, two membrane-spanning domains, and a large extracellular loop.


Subject(s)
Ion Channel Gating/physiology , Receptors, Purinergic P2/chemistry , Adenosine Triphosphate/pharmacology , Amino Acid Sequence , Animals , Cell Line , Dimerization , Electrophysiology , Glycosylation , Hexosaminidases/metabolism , Humans , Membrane Proteins/chemistry , Molecular Sequence Data , Molecular Weight , Mutagenesis, Site-Directed/genetics , Oocytes/physiology , Receptors, Purinergic P2X2 , Transfection/genetics , Xenopus laevis
16.
Neuropharmacology ; 36(9): 1229-42, 1997 Sep.
Article in English | MEDLINE | ID: mdl-9364478

ABSTRACT

Of the cloned P2X receptor subunits, six are expressed in sensory neurons, suggesting that the native channels may be heteromultimers with diverse composition. It has been proposed that P2X2 and P2X3 form heteromultimers in sensory neurons. We further tested this hypothesis by examining the relationship of P2X2 and P2X3 immunocytochemically. In rat dorsal root and nodose ganglia, P2X2- and P2X3-immunoreactivity (-ir) were highly colocalized, although single-labeled cells were also present. In dorsal root ganglia (DRG), in some cases P2X2-ir appeared to be present in satellite cells. In dorsal horn of spinal cord, at low magnification the laminar localization of P2X2- and P2X3-ir overlapped, but at high magnification colocalization was rarely observed. In contrast, in the solitary tract and its nucleus (NTS), colocalization of P2X2- and P2X3-ir was seen at low and high magnification. These results suggest that the relationship of P2X2- and P2X3-ir is different in nodose and dorsal root ganglia and might reflect differences in the targeting of P2X receptors in different sensory neurons. In monkey, P2X2-ir was observed in DRG neurons and satellite cells and in dorsal horn of spinal cord. P2X3-ir was also seen in DRG neurons. However, the presence of P2X2-ir in NTS as well as the presence of P2X3-ir in spinal cord and NTS could not be established definitively. These results suggest species differences, although a more extensive study of primate sensory systems is necessary.


Subject(s)
Nerve Endings/chemistry , Neurons, Afferent/chemistry , Receptors, Purinergic P2/chemistry , Animals , Blotting, Western , Brain Stem/chemistry , Cell Line , Female , Fluorescent Antibody Technique, Indirect , Ganglia, Spinal/chemistry , Humans , In Vitro Techniques , Kidney/cytology , Kidney/embryology , Macaca mulatta , Male , Microscopy, Confocal , Nodose Ganglion/chemistry , Rats , Receptors, Purinergic P2X2 , Receptors, Purinergic P2X3 , Spinal Cord/chemistry , Transfection
17.
Neuropharmacology ; 36(9): 1277-83, 1997 Sep.
Article in English | MEDLINE | ID: mdl-9364482

ABSTRACT

The P2X7 receptor is a bifunctional molecule. The binding of ATP induces within milliseconds the opening of a channel selective for small cations, and within seconds a larger pore opens which allows permeation by molecules as large as propidium dyes (629 Da). In situ hybridization using a digoxigenin-labelled riboprobe, and immunohistochemistry using an antibody raised against a C-terminal peptide sequence, were used to determine the distribution of the P2X7 receptor mRNA and protein in rat and mouse tissues and cell lines. The brain of newborn rats showed a 6 kb RNA by Northern blotting, but this was not detectable in adult brain. By in situ hybridization and immunohistochemistry, there was heavy labelling of ependymal cells in both newborn and adult brain, but the brain parenchyma showed no labelling. However, P2X7 receptor-immunoreactive cells appeared in the penumbral region around an area of necrosis evoked by prior occlusion of the middle cerebral artery, suggesting expression of the receptor by activated microglia. NTW8 cells, a mouse microglial cell line, strongly expressed the P2X7 receptor mRNA and protein. The P2X7 receptor mRNA and protein were also observed in the majority of bone marrow cells, including those separately identified by their expression of other antigens as granulocytes, monocyte/macrophages and B lymphocytes. The expression of P2X7 receptor by brain macrophages rather than neurons would be consistent with a role in brain repair following inflammation, infarction or immune insult.


Subject(s)
Receptors, Purinergic P2/metabolism , Animals , Animals, Newborn , Blotting, Northern , Blotting, Western , Cell Line , Embryo, Mammalian , Female , Hematopoietic System/metabolism , Immunoenzyme Techniques , In Situ Hybridization , Macrophages/metabolism , Male , Mice , Mice, Inbred C57BL , Nervous System/metabolism , Pregnancy , RNA, Messenger/metabolism , Rats , Rats, Sprague-Dawley , Receptors, Purinergic P2X7 , Tissue Distribution
18.
Neuropharmacology ; 36(9): 1295-301, 1997 Sep.
Article in English | MEDLINE | ID: mdl-9364484

ABSTRACT

Microglial cells are known to express purinergic receptors for extracellular ATP of both the P2Y and P2X subtypes. Functional studies have shown that both primary mouse microglial cells and the N9 and N13 microglial cell lines express the pore-forming P2Z/P2X7 receptor. Here we identify the presence of this receptor in N9 and N13 cells with a specific polyclonal Ab and show that microglial cells expressing the P2Z/P2X7 receptor are exquisitively sensitive to ATP-mediated cytotoxicity while clones selected for the lack of this receptor are resistant. Transfection of HEK293 cells with P2X7 (but not P2X2) receptor cDNA confers susceptibility to ATP-mediated cytotoxicity. Morphological and biochemical analysis suggests that ATP-dependent cell death in microglial cells occurs by apoptosis. Finally, microglial cells release ATP via a non-lytic mechanism when activated by bacterial endotoxin, thus suggesting the operation of a purinergic autocrine/paracrine loop.


Subject(s)
Adenosine Triphosphate/physiology , Apoptosis/drug effects , Microglia/drug effects , Adenosine Triphosphate/metabolism , Animals , Blotting, Western , Cell Line , DNA Fragmentation/drug effects , In Vitro Techniques , Kidney/enzymology , L-Lactate Dehydrogenase/metabolism , Mice , Microglia/enzymology , Microscopy, Phase-Contrast , Receptors, Purinergic P2/metabolism , Receptors, Purinergic P2X2 , Receptors, Purinergic P2X7 , Transfection
19.
J Cell Biol ; 138(3): 697-706, 1997 Aug 11.
Article in English | MEDLINE | ID: mdl-9245796

ABSTRACT

Mouse and human macrophages express a plasma membrane receptor for extracellular ATP named P2Z/P2X7. This molecule, recently cloned, is endowed with the intriguing property of forming an aqueous pore that allows transmembrane fluxes of hydrophylic molecules of molecular weight below 900. The physiological function of this receptor is unknown. In a previous study we reported experiments suggesting that the P2Z/P2X7 receptor is involved in the formation of macrophage-derived multinucleated giant cells (MGCs; Falzoni, S., M. Munerati, D. Ferrari, S. Spisani, S. Moretti, and F. Di Virgilio. 1995. J. Clin. Invest. 95:1207- 1216). We have selected several clones of mouse J774 macrophages that are characterized by either high or low expression of the P2Z/P2X7 receptor and named these clones P2Zhyper or P2Zhypo, respectively. P2Zhyper, but not P2Zhypo, cells grown to confluence in culture spontaneously fuse to form MGCs. As previously shown for human macrophages, fusion is inhibited by the P2Z/P2X7 blocker oxidized ATP. MGCs die shortly after fusion through a dramatic process of cytoplasmic sepimentation followed by fragmentation. These observations support our previous hypothesis that the P2Z/P2X7 receptor is involved in macrophage fusion.


Subject(s)
Cell Fusion , Macrophages/cytology , Receptors, Purinergic P2/metabolism , Adenosine Triphosphate/analogs & derivatives , Adenosine Triphosphate/pharmacology , Animals , Cell Aggregation , Cell Fusion/drug effects , Cell Line , Giant Cells/cytology , Hexokinase/pharmacology , Humans , Macrophages/drug effects , Macrophages/metabolism , Mice , Phenotype , Purinergic P2 Receptor Antagonists , Receptors, Purinergic P2X7
20.
EMBO J ; 16(12): 3446-54, 1997 Jun 16.
Article in English | MEDLINE | ID: mdl-9218787

ABSTRACT

P2X receptors are ion channels opened by extracellular ATP. The seven subunits currently known are encoded by different genes. It is thought that each subunit has two transmembrane domains, a large extracellular loop, and intracellular N- and C-termini, a topology which is fundamentally different from that of other ligand-gated channels such as nicotinic acetylcholine or glutamate receptors. We used the substituted cysteine accessibility method to identify parts of the molecule that form the ionic pore of the P2X2 receptor. Amino acids preceding and throughout the second hydrophobic domain (316-354) were mutated individually to cysteine, and the DNAs were expressed in HEK293 cells. For three of the 38 residues (I328C, N333C, T336C), currents evoked by ATP were inhibited by extracellular application of methanethiosulfonates of either charge (ethyltrimethylammonium, ethylsulfonate) suggesting that they lie in the outer vestibule of the pore. For two further substitutions (L338C, D349C) only the smaller ethylamine derivative inhibited the current. L338C was accessible to cysteine modification whether or not the channel was opened by ATP, but D349C was inhibited only when ATP was concurrently applied. The results indicate that part of the pore of the P2X receptor is formed by the second hydrophobic domain, and that L338 and D349 are on either side of the channel 'gate'.


Subject(s)
Ion Channels/chemistry , Receptors, Purinergic P2/chemistry , Adenosine Triphosphate/pharmacology , Binding Sites , Cell Line , Cysteine/chemistry , Electrophysiology , Ethylamines/pharmacology , Humans , Ion Channel Gating , Ion Channels/genetics , Mesylates/pharmacology , Mutagenesis , Quaternary Ammonium Compounds/pharmacology , Receptors, Purinergic P2/genetics , Receptors, Purinergic P2X2
SELECTION OF CITATIONS
SEARCH DETAIL
...